Evidence map›Paper›PMID 3893489›Full record

Trial reportBritish heart journal1985

Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction.

P K Rønnevik, T Gundersen, A M Abrahamsen

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in British heart journal, 1985. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Smoking cessation for secondary prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Observational
  3. Informal care and health behaviors among elderly people with chronic diseases.Journal of health, population, and nutrition · 2017
    Article
  4. Article
  5. Health behavior change following chronic illness in middle and later life.The journals of gerontology. Series B, Psychological sciences and social sciences · 2012
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

P K Rønnevik
T Gundersen
A M Abrahamsen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Norwegian Multicenter Group Study noted the effect of smoking habits before and after myocardial infarction and their relation to mortality and reinfarction rate after treatment with timolol in patients surviving acute myocardial infarction. The mean follow up period was 17.3 (range 12-33) months. No relation was found between initial smoking habits and risk category after infarction or between initial smoking habits and later outcome. At the time of their first infarct smokers were seven years younger than non-smokers. One moth after infarction nearly 60% of the smokers had stopped smoking completely. A significantly lower incidence of early cardiac death and lower total mortality was found in patients treated with timolol in both those who continued smoking and in the combined non-smoking groups and a significantly lower reinfarction rate among non-smokers. Cessation of smoking alone was associated with a reduced reinfarction rate by 45% but a non-significant reduction in mortality by 26%. It is concluded that treatment with timolol and cessation of smoking have an additive effect in reducing mortality and reinfarction rate after myocardial infarction.

Indexed as

SmokingAgedClinical Trials as TopicFemaleHumansMaleMiddle AgedMyocardial InfarctionRandom AllocationRecurrenceRiskTimololTimolol

Identifiers

PMID3893489
PMCPMC481867
OpenAlexW2052593818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.